A detailed history of Checkpoint Capital L.P. transactions in A Tyr Pharma Inc stock. As of the latest transaction made, Checkpoint Capital L.P. holds 1,736,477 shares of LIFE stock, worth $3.23 Million. This represents 1.52% of its overall portfolio holdings.

Number of Shares
1,736,477
Previous 1,946,477 10.79%
Holding current value
$3.23 Million
Previous $3.04 Billion 0.65%
% of portfolio
1.52%
Previous 1.83%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$1.51 - $2.24 $317,100 - $470,400
-210,000 Reduced 10.79%
1,736,477 $3.06 Billion
Q2 2024

Aug 14, 2024

BUY
$0.0 - $2.07 $0 - $1.03 Million
500,000 Added 34.57%
1,946,477 $3.04 Billion
Q1 2024

May 15, 2024

SELL
$1.42 - $2.02 $81,049 - $115,295
-57,077 Reduced 3.8%
1,446,477 $2.82 Billion
Q4 2023

Feb 14, 2024

BUY
$1.11 - $1.51 $1.67 Million - $2.27 Million
1,503,554 New
1,503,554 $2.12 Billion

Others Institutions Holding LIFE

About aTYR PHARMA INC


  • Ticker LIFE
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 28,625,000
  • Market Cap $53.2M
  • Description
  • aTyr Pharma, Inc., a biotherapeutics company, engages in the discovery and development of medicines based on novel immunological pathways in the United States. The company's lead therapeutic candidate is efzofitimod, a selective modulator of NRP2 that is in Phase II clinical trial for pulmonary sarcoidosis; and in Phase 1b/2a clinical trial for ...
More about LIFE
Track This Portfolio

Track Checkpoint Capital L.P. Portfolio

Follow Checkpoint Capital L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Checkpoint Capital L.P., based on Form 13F filings with the SEC.

News

Stay updated on Checkpoint Capital L.P. with notifications on news.